M Knight1. 1. National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK. marian.knight@npeu.ox.ac.uk
Abstract
OBJECTIVES: To identify women undergoing peripartum hysterectomy in the UK and to describe the causes, management and outcome of the associated haemorrhage. DESIGN: A population-based descriptive study using the UK Obstetric Surveillance System (UKOSS). SETTING: All 229 hospitals with consultant-led maternity units in the UK. POPULATION: All women in the UK delivering between February 2005 and February 2006. METHODS: Prospective case identification through the UKOSS monthly mailing. MAIN OUTCOME MEASURES: Rates with 95% CIs. Odds ratio estimates. RESULTS: Three hundred and eighteen women underwent peripartum hysterectomy. The most commonly reported causes of haemorrhage were uterine atony (53%) and morbidly adherent placenta (39%). Women were not universally managed with uterotonic therapies. Fifty women were unsuccessfully managed with B-Lynch or other brace suture prior to hysterectomy, 28 with activated factor VII and 9 with arterial embolisation. Twenty-one percent of women suffered damage to other structures, 20% required a further operation and 19% were reported to have additional severe morbidity. Bladder damage was more likely in women with placenta accreta (OR 3.41, 95% CI 1.55-7.48) than in women with uterine atony. There were no significant differences in outcomes between women undergoing total or subtotal hysterectomy. Two women died; case fatality 0.6% (95% CI 0-1.5%). CONCLUSIONS: For each woman who dies in the UK following peripartum hysterectomy, more than 150 survive. The associated haemorrhage is managed in a variety of ways and not universally according to existing guidelines. Further investigation of the outcomes following some of the more innovative therapies for control of haemorrhage is needed.
OBJECTIVES: To identify women undergoing peripartum hysterectomy in the UK and to describe the causes, management and outcome of the associated haemorrhage. DESIGN: A population-based descriptive study using the UK Obstetric Surveillance System (UKOSS). SETTING: All 229 hospitals with consultant-led maternity units in the UK. POPULATION: All women in the UK delivering between February 2005 and February 2006. METHODS: Prospective case identification through the UKOSS monthly mailing. MAIN OUTCOME MEASURES: Rates with 95% CIs. Odds ratio estimates. RESULTS: Three hundred and eighteen women underwent peripartum hysterectomy. The most commonly reported causes of haemorrhage were uterine atony (53%) and morbidly adherent placenta (39%). Women were not universally managed with uterotonic therapies. Fifty women were unsuccessfully managed with B-Lynch or other brace suture prior to hysterectomy, 28 with activated factor VII and 9 with arterial embolisation. Twenty-one percent of women suffered damage to other structures, 20% required a further operation and 19% were reported to have additional severe morbidity. Bladder damage was more likely in women with placenta accreta (OR 3.41, 95% CI 1.55-7.48) than in women with uterine atony. There were no significant differences in outcomes between women undergoing total or subtotal hysterectomy. Two women died; case fatality 0.6% (95% CI 0-1.5%). CONCLUSIONS: For each woman who dies in the UK following peripartum hysterectomy, more than 150 survive. The associated haemorrhage is managed in a variety of ways and not universally according to existing guidelines. Further investigation of the outcomes following some of the more innovative therapies for control of haemorrhage is needed.
Authors: Alexander M Friedman; Jason D Wright; Cande V Ananth; Zainab Siddiq; Mary E D'Alton; Brian T Bateman Journal: Am J Obstet Gynecol Date: 2016-06-24 Impact factor: 8.661
Authors: Shravya Govindappagari; Jason D Wright; Cande V Ananth; Yongmei Huang; Mary E DʼAlton; Alexander M Friedman Journal: Obstet Gynecol Date: 2016-12 Impact factor: 7.661
Authors: Elena V Kuklina; Susan F Meikle; Denise J Jamieson; Maura K Whiteman; Wanda D Barfield; Susan D Hillis; Samuel F Posner Journal: Obstet Gynecol Date: 2009-02 Impact factor: 7.661